Skip to main content

Active Pharmaceutical Ingredient Market Going to Reach US$ 225.2 Bn by 2025

An active pharmaceutical ingredient is used in a finished pharmaceutical product (FPP), intended to carry certain pharmacological actions or otherwise have a direct effect in the diagnosis, cure, treatment, mitigation or prevention of various diseases, or in some cases in restoring, correcting or modifying human physiological functions. Sales of pharmaceutical ingredient are on the rise due to a substantial increase in high-potency API (HPAPI) and peptide API manufacturing. A new study conducted by Persistence Market Research reveals that the US$ 151.9 Bn global active pharmaceutical ingredient market will grow to US$ 158.3 Bn by 2017 end, reflecting a Y-o-Y growth rate of 4.2%. This market is estimated to further increase to US$ 225.2 Bn, expanding at a CAGR of 4.5% over the forecast period (2016–2025)



PMR in its report, titled “Active Pharmaceutical Ingredient Market — Global Industry Analysis and Forecast, 2016–2025” has cited some of the key factors prompting the global sales of API, which include:
  • Higher emphases on the development of novel therapeutics that contain high-potency active pharmaceutical ingredients (HPAPIs).

  • Ramped-up investments from large-scale API manufacturers and contract manufacturers in production of high potency API.

  • The lower cost of labor cost and abundance of raw materials continue to facilitate the growth of API market in the Asia region.

  • Faster approvals of API based peptide and diabetes management drugs. Over the recent past, a range of peptide drugs has been approved treatment of type 2 Diabetes Mellitus including Albiglutide (GSK), Dulaglutide (Eli Lilly), Exenatide (Amylin Pharmaceuticals) and Glucagon (Xeris Pharmaceuticals).

Download Report Table of Content, Figures, and Tables @http://www.persistencemarketresearch.com/market-research/active-pharmaceutical-ingredient-market/toc
According to the report, small molecule API type segment holds promising investment opportunities for market participants on account of the numerous off-patent events incurred in the last five years coupled with a strong penetration of small scale manufacturers in Asia. On the basis region, APAC’s API market was valued at US$ 61.4 Bn in 2016 and is projected to witness the highest CAGR of 5.1 % during the forecast period to reach a valuation of US$ 95.6 Bn. This is primarily owing to the leadership of China and India in SMEs as well as their strong distribution network in overseas markets especially in US, South Africa, and Europe. Asian pharmaceuticals CMOs are competing on the basis of cost and timeline for API manufacturing and are attracting U.S.-based pharmaceuticals companies that are willing to outsource manufacturing requirements. Meanwhile, Europe is projected to be the second fastest growing market for API and is expected to reach US$ 42.5 Bn by 2025-end. Manufacturers in Europe are prioritizing high-quality standards, advanced manufacturing installations, and high purity of intermediates (API).
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/11260
Johnson Matthey, Siegfried, Almac, PolyPeptide Laboratories, AmbioPharm, Inc., Corden Pharma, Pepscan, BCN peptide, Provence Technologies Groups, SennChemicals AG, Avecia OligoMedicines, Santaris Pharma — acquired by Roche in 2014, ST Pharm Oligo Center, Cepia Sanofi, Biospring, Pfizer CenterSource, Symbiotec Pharma Lab Pvt. Ltd., Gadea Grupo Farmacéutico, STEROID S.p.A., Dolder AG, Dalton Pharma Services, FarmaBios Spa, Dextra Laboratories Limited, GlycoSyn, Inalco Pharma, Sussex Research, Pfanstiehl, Inc., Noramco, Inc., Johnson Matthey, Siegfried, Rhodes Technologies, Ash Stevens, Fermion (public), FARMHISPANIA GROUP, Olon SpA, Lonza Group are some of the leading companies operating in the global active pharmaceutical ingredient market. Currently, many of the pharmaceutical companies are focused on outsourcing of API manufacturing to avoid large capital investments in setting up of API manufacturing facilities. This has accelerated the demand for CMOs in API manufacturing industry, which is dominated by small to medium manufacturers.
Browse Complete Report @ http://www.persistencemarketresearch.com/market-research/active-pharmaceutical-ingredient-market.asp
Labels:

Comments

Post a Comment

Popular posts from this blog

Australia & New Zealand Herbal Supplements Market to Expand US$ 760.9 Mn by 2025

According to the report, titled “ Herbal Supplements Market: Australia & New Zealand Industry Analysis and Forecast, 2017–2025 ,” the market is expected to bring in US$ 434.9 Mn by the end of 2017. In the eight-year forecast period, the herbal supplement revenues in Australia & New Zealand will have soared at an impressive 7.2% CAGR. The region’s rich dietary culture and growing per capita healthcare expenditure will continue to favor the growth of its herbal supplements market. Increasing demand for herbal supplements to strengthen one’s immunity and a sizeable population of baby boomers are two crucial factors driving the sales of herbal supplements in Australia and New Zealand. Balancing diets of the common people continues to be a top priority of governments witnessing an alarming rise in food-related disorders. Some regions are augmenting their staple foods while others are adopting new edible products in their nutritionally deficient diets. On the same lines, the de...
Post a Comment
Read more

Fifth Wheel Coupling Market Projected to Value US$ 700 Mn by 2025

Persistence Market Research presents a new report titled ‘Fifth Wheel Coupling Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025’ that studies the performance of the global fifth wheel coupling market over an eight year assessment period from 2017 to 2025. The report presents the value and volume forecasts of the global fifth wheel coupling market and provides important insights into the factors driving market growth as well as the factors restricting market growth. As per the assessment of Persistence Market Research, the global fifth wheel coupling market was estimated to be valued at nearly US$ 460 Mn in 2017 and is anticipated to touch a valuation of nearly US$ 700 Mn in 2025 and in the process exhibit a CAGR of 5.4% during the period of forecast 2017-2025. Advanced Material Technology Positively Impacting the Global Fifth Wheel Coupling Market The adoption of advanced material technology in automobile components increases the load capacity as well as st...
Post a Comment
Read more

Building Automation Systems Market Will Amass at 11.1% CAGR by 2026

In reference to a new report published by Persistence Market Research, the global  building automation systems market  will showcase significant growth between 2016 and 2026. Manufacturers of building automation systems are rapidly adopting new regulations set across the globe and they are also lining up new products to meet rising market demand. The Persistence Market Research report titled,  “Building Automation Systems Market: Global Industry Analysis & Forecast, 2016-2026”,  talks in detail about the market psyche and also scrutinizes the market drifts which are expected to impact the future of the global building automation systems market. The global building automation systems market was valued more than US$ 43 Bn in 2015 and is expected to mint better revenue by the end of 2016, reaching approximately US$ 48 Bn. The market will continue its journey towards expansion and the market worth will reach US$ 141.1 Bn towards the end of 2026. The global building...
Post a Comment
Read more